These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 18256367)
21. Using medication history to measure confounding by indication in assessing calcium channel blockers and other antihypertensive therapy. Leader S; Mallick R; Roht L J Hum Hypertens; 2001 Mar; 15(3):153-9. PubMed ID: 11317198 [TBL] [Abstract][Full Text] [Related]
22. Association between beta-blockers, other antihypertensive drugs and psoriasis: population-based case-control study. Brauchli YB; Jick SS; Curtin F; Meier CR Br J Dermatol; 2008 Jun; 158(6):1299-307. PubMed ID: 18410416 [TBL] [Abstract][Full Text] [Related]
23. Use of thiazolidinediones and fracture risk. Meier C; Kraenzlin ME; Bodmer M; Jick SS; Jick H; Meier CR Arch Intern Med; 2008 Apr; 168(8):820-5. PubMed ID: 18443256 [TBL] [Abstract][Full Text] [Related]
24. Duration of antihypertensive drug use and risk of dementia: A prospective cohort study. Haag MD; Hofman A; Koudstaal PJ; Breteler MM; Stricker BH Neurology; 2009 May; 72(20):1727-34. PubMed ID: 19228584 [TBL] [Abstract][Full Text] [Related]
25. A cohort study of antihypertensive medication use and breast cancer among Danish women. Fryzek JP; Poulsen AH; Lipworth L; Pedersen L; Nørgaard M; McLaughlin JK; Friis S Breast Cancer Res Treat; 2006 Jun; 97(3):231-6. PubMed ID: 16791484 [TBL] [Abstract][Full Text] [Related]
26. [Effects of antihypertensive drugs on glucose metabolism and cardiovascular events]. Landmark K; Reikvam A Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1740-4. PubMed ID: 19756054 [TBL] [Abstract][Full Text] [Related]
27. Antihypertensive drugs and risk of venous thromboembolism: results from the EDITH case-control study. Belattar FZ; Delluc A; Le Gal G; Leroyer C; Mottier D; Oger E; Lacut K Fundam Clin Pharmacol; 2010 Apr; 24(2):255-9. PubMed ID: 19686532 [TBL] [Abstract][Full Text] [Related]
28. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors. Fournier A; Oprisiu-Fournier R; Serot JM; Godefroy O; Achard JM; Faure S; Mazouz H; Temmar M; Albu A; Bordet R; Hanon O; Gueyffier F; Wang J; Black S; Sato N Expert Rev Neurother; 2009 Sep; 9(9):1413-31. PubMed ID: 19769454 [TBL] [Abstract][Full Text] [Related]
29. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy. Patel BV; Remigio-Baker RA; Thiebaud P; Preblick R; Plauschinat C BMC Fam Pract; 2008 Nov; 9():61. PubMed ID: 18990240 [TBL] [Abstract][Full Text] [Related]
30. First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review. Sung SK; Lee SG; Lee KS; Kim DS; Kim KH; Kim KY Clin Ther; 2009 Jun; 31(6):1309-20. PubMed ID: 19695396 [TBL] [Abstract][Full Text] [Related]
31. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial. Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA; J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281 [TBL] [Abstract][Full Text] [Related]
32. Calcium-entry blockers-induced parkinsonism: possible role of inherited susceptibility. Negrotti A; Calzetti S; Sasso E Neurotoxicology; 1992; 13(1):261-4. PubMed ID: 1508427 [TBL] [Abstract][Full Text] [Related]
33. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives. Bozkurt O; Verschuren WM; van Wieren-de Wijer BM; Knol MJ; de Boer A; Grobbee DE; Geerlings MI; Heerdink ER; Klungel OH J Hum Hypertens; 2008 Nov; 22(11):774-80. PubMed ID: 18563171 [TBL] [Abstract][Full Text] [Related]
34. Family-based case-control study of cigarette smoking and Parkinson disease. Scott WK; Zhang F; Stajich JM; Scott BL; Stacy MA; Vance JM Neurology; 2005 Feb; 64(3):442-7. PubMed ID: 15699372 [TBL] [Abstract][Full Text] [Related]
35. Professional exposure to pesticides and Parkinson disease. Elbaz A; Clavel J; Rathouz PJ; Moisan F; Galanaud JP; Delemotte B; Alpérovitch A; Tzourio C Ann Neurol; 2009 Oct; 66(4):494-504. PubMed ID: 19847896 [TBL] [Abstract][Full Text] [Related]
36. Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis. Alonso A; Jick SS; Hernán MA Neurology; 2006 Feb; 66(4):572-5. PubMed ID: 16505314 [TBL] [Abstract][Full Text] [Related]
37. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction. Austin PC; Tu JV; Ko DT; Alter DA CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455 [TBL] [Abstract][Full Text] [Related]
38. The metabolic syndrome in hypertension: European society of hypertension position statement. Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G; J Hypertens; 2008 Oct; 26(10):1891-900. PubMed ID: 18806611 [TBL] [Abstract][Full Text] [Related]
39. Antidepressant drug use and risk of venous thromboembolism. Jick SS; Li L Pharmacotherapy; 2008 Feb; 28(2):144-50. PubMed ID: 18225961 [TBL] [Abstract][Full Text] [Related]
40. Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment. Poon IO Pharmacotherapy; 2008 Mar; 28(3):366-75. PubMed ID: 18294116 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]